胫骨定量超声测量及临床应用探讨

用ＳｏｕｎｄＳｃａｎ２０００骨定量超声（ＱＵＳ）仪测量胫骨超声速度（ＳＯＳ），同时与单光子吸收法（ＳＰＡ）测量前臂１／３处骨矿密度（ＢＭＤ）比较。两方法测得２０８例患者和健康志愿者结果相关（ｒ＝０．６７８，Ｐ＜０．００１）。４２例健康绝经妇女ＳＯＳ和ＢＭＤ与绝经时间呈负相关（ｒ＝－０．４１７和－０．４７９，Ｐ＜０．０１），７３例＞４０岁的健康志愿者ＳＯＳ和ＢＭＤ与年龄呈负相关（ｒ＝－０．２９３和－０．３７３，Ｐ＜０．０５）。与性别和年龄相匹配的正常参考值比较，结果＜ｘ－２ｓ者ＱＵＳ检出３４例，占１６．３％；ＳＰＡ２３例，占１１．０％，ＱＵＳ的诊断敏感度约是ＳＰＡ的１．５倍。     

双能X线吸收法及定量CT法诊断骨质疏松症的比较研究

本研究比较了双能Ｘ线吸法（ＤＸＡ）与定量ＣＴ（ＱＣＴ）在骨质疏松症诊断中的应用。对５６例健康妇女（Ｈ组）及４８例骨折后骨质疏松妇女（ＯＰ组）进行了ＤＸＡ及ＱＣＴ测量。ＤＸＡ与ＱＣＴ在Ｈ、ＯＰ组均显著相关（ｒ＝０．７５，Ｐ＜０．０００１，ｒ＝０．５８，Ｐ＜０．０００１）。Ｈ组及ＯＰ组，随年龄增长的骨减少率，ＱＣＴ较ＤＸＡ法为高。而两组中骨密度的差别，ＱＣＴ较ＤＸＡ法更大（Ｐ＜０．０５）。结论；由于ＱＣＴ可以选择性测量椎体松质骨，故可较ＤＸＡ更能很好地区分健康人与骨质疏松病人。     

双能X线和单光子吸收法及定量超声诊断骨质疏松症的比较

了解三种方法诊断骨质疏松症（ＯＰ）之间的关系。方法应用双能Ｘ线吸收法（ＤＸＡ）和单光子吸收法（ＳＰＡ）及定量超声（ＱＵＳ），同时随机测量２９４例受试者腰椎后前位和侧位、左侧髓部和前臂骨矿密度（ＢＭＤ）及右侧胫骨超声速度（ＳＯＳ）。结果ＤＸＡ和ＳＰＡ测量桡骨ＯＰ的检出率分别为２５．９％和２１．４％，ＤＸＡ测量腰椎后前位、侧位、侧位兴趣区、Ｗａｒｄ’ｓ区和股骨颈ＯＰ检出率分别为１６．０％、２２．８％、２６．２％、１９．４％和４．４２％，ＱＵＳ的ＯＰ检出率为１７．７％。三种方法及不同部位之间的测量结果呈显著相关（ｒ＝０．４９４～０．９６７，Ｐ＜０．０１）。ＤＸＡ测量前臂１／３处ＢＭＤ显著高于ＳＰＡ。诊断ＯＰ的齐同率ＤＸＡ各部位相互之间平均为４０．１％±１５．５％，ＤＸＡ与ＳＰＡ平均为４８．４％±１９．０％，ＱＵＳ与ＤＸＡ和ＳＰＡ平均为３８．８％±１０．２％，各平均值之间无显著差异。结论ＯＰ的检出率取决于受检部位，腰椎侧位兴趣区和挠骨是检出率最高的部位，股骨颈和尺骨是最低的部位。ＳＰＡ与ＤＸＡ测量前臂ＢＭＤ高度相关，诊断结果无显著性差别。     

上海地区正常人群胫骨定量超声骨量的分布及临床应用研究

目的　胫骨定量超声测量（ＱＵＳ）的临床意义研究及与ＤＥＸＡ 法的比较。方法　对４５８ 名社区健康志愿者人群（年龄２０～７９ 岁）进行胫骨定量超声骨量（ＱＵＳ）的测量研究。结果　ＳＯＳ值在男、女性中,均在３０～３９ 岁达到峰值,女性在５０ 岁以后ＳＯＳ值急剧下降,同时伴随着身高缩短,男性人群在５０ 岁以后的ＳＯＳ值仍维持在较高的水平,从而使男、女性在５０ 岁以后显示出明显的性别差异（Ｐ＜ ０．０１）。在绝经后妇女中,胫骨ＳＯＳ值与年龄和绝经年限均呈明显的负相关,其中绝经对骨密度值的下降起着重要作用。此外,胫骨ＳＯＳ值与腰椎骨密度值中度相关（ｒ＝ ０．５０,Ｐ＜ ０．０１）。结论　胫骨定量超声声速的测量,能很好地反映健康人群的骨量变化情况,对开展人群的普查普防,以早期诊断骨质疏松症和预测骨折的危险性,有应用潜力。     

桡骨骨密度与股骨颈及腰椎骨密度的比较分析

通过分析桡骨骨密度与股骨颈及腰椎骨密度，了解它们之间的相关性，为选择预测骨折的最佳部位提供依据。选取健康人群１００例，其中男性５３例，女性４７例；骨质疏松患者１１例。采用日本ＡＬＯＫＡ公司生产的ＤＣＳ－６００ＥＸ型双能Ｘ线骨密度仪和美国ＬＵＮＡＲ公司生产的ＤＰＸ－Ｌ型骨密度仪对比测量，选择的部位为前臂、股骨颈及腰椎。两种仪器的前臂１／１０点与腰椎骨的密度值相关性非常好（ｒ＝０．６６１），而１／３点相关性则较差（ｒ＝０．３３２），说明在前臂桡骨骨远端，松质骨比重较大，代谢较快，骨矿物含量变化最为敏感，此部位能代替腰椎骨作为骨质疏松的诊断指标。另外，两种仪器的前臂１／１０点与髋部骨密度值相关性也非常好（ｒ＝０．７９２）。表明在桡骨骨远端骨矿物含量的结果中，可以了解髋部骨量变化的信息。就前臂同一部位两种仪器的测量结果看ＤＣＳ－６００ＥＸ型的１／３点和１／１０点与ＤＰＸ－Ｌ型的１／３点和１／１０点的测定值相关性都非常好，绝对值基本上均在误差范围之内，说明骨矿含量的变化程度在两种仪器上的测量显示相同的结果。     

超声心动图测量左房内径在室间隔缺损或动脉导管未闭中应用价…

本文应用ＳＳＨ－６５Ａ彩色超声心动图仪测量１５例室间隔缺损（ＶＳＤ）和４例动脉导管未闭（ＰＤＡ）患儿的左房内径（ＬＡＤ）和主动脉根径（ＡＯＤ）以及ＶＳＤ的直径（Ｄ），并与健康者及手术后所测值进行对比分析。结果表明：患儿的ＬＡＤ和ＬＡＤＩ（左房内径指数）高于正常者（Ｐ〈０．０１）且ＬＡＤＩ与Ｄ／ＡＯＤ具有相关性，其回归方程为Ｄ／ＡＯＤ＝０．０４４ＬＡＤＩ－１．２１（ｒ＝０．８５，Ｐ〈０．０１），但其     

DEXA、QUS在绝经后骨质疏松脊柱骨折诊断中的应用与探讨

目的 探讨对比绝经后骨质疏松患ＤＥＸＡ与ＱＵＳ测量对骨质疏松脊椎骨折的预测能力。方法：应用双能Ｘ线骨密度仪（ＤＥＸＡ,Ｌｕｎａｒ,ＤＰＸ－ＩＱ）和超声骨强度仪（ＱＵＳ,Ｓｕｍｌｉｇｈｔ Ｏｍ－ｎｉｓｅｎｓｅ,Ｒｅｓｅａｒｃｈ）对４９例绝经后骨质疏松脊柱骨折患脊柱、股骨近端和桡骨、戏骨进行测定、比较。结果 ４９例患ＤＥＸＡ腰椎ＢＭＤ－Ｔ值为－２．９９±１．４３,股骨近端ＢＭＤ－Ｔ值为－１．９５     

绝经后女性类风湿性关节炎患者腰椎和股骨近端骨密度测量

为了观察绝经后女性类风湿性关节炎（ＲＡ）患者骨矿物质密度水平的变化，采用双能Ｘ线骨密度仪（ＤＥＸＡ）测量２３例绝经后女性ＲＡ患者和年龄、性别匹配的２３例正常健康者的腰椎２～４（Ｌ２～Ｌ４）和右侧股骨近端（股骨颈、大转子和Ｗａｒｄ＇ｓ三角区）的骨密度（ＢＭＤ）。结果表明，绝经后女性ＲＡ患者Ｌ２～Ｌ４、右侧股骨近端的ＢＭＤ测量值（ｇ／ｃｍ２）明显低于年龄和性别匹配的正常健康者（Ｐ＜０．０５）。绝经后女性ＲＡ患者Ｌ２～Ｌ４骨密度的Ｚ－ｓｃｏｒｅ与糖皮质激素用药时间呈显著负相关（ｒ＝－０．５８，Ｐ＝０．００３，ｎ＝２３）。提示绝经后女性ＲＡ患者存在明显的骨质丢失。     

骨代谢生化指标随年龄的变化及其临床意义

本文收集了北京地区１９２８名不同年龄（０～８７岁）健康人及５３４５例２０余种疾病患者空腹尿及血，并对其骨代谢生化指标进行测定。结果表明：血清２５羟基维生素Ｄ（２５ＯＨＤ），碱性磷酸酶（ＡＬＰ），骨钙素（ＢＧＰ），甲状旁腺激素（ＰＴＨ），尿Ⅰ型胶原交联Ｎ末端肽与肌酐比值（ＮＴＸ／Ｃｒ）及羟脯氨酸与肌酐比值（ＨＯＰ／Ｃｒ）与年龄显著相关。血清２５ＯＨＤ，ＢＧＰ，尿ＮＴＸ／Ｃｒ及ＨＯＰ／Ｃｒ可用于预测骨量。１，２５（ＯＮ）２Ｄ３，２５ＯＨＤ，ＮＴＸ／Ｃｒ和ＮＯＰ／Ｃｒ可用于区分绝经前与绝经后骨质疏松妇女。与年龄有关的骨丢失可能与１，２５（ＯＨ）２Ｄ３的降低、ＰＴＨ的升高及肾功能减退有关；绝经后骨丢失与雌激素缺乏有关。     

多囊卵巢综合征的高胰岛素血症与神经肽

对多囊卵巢综合征（ＰＣＯＳ）患者２０例及以已婚经产健康妇女１０名为对照组，行口服葡萄糖耐量试验（ＯＧＴＴ），以观察内源性神经肽及生长抑素（ＳＳ）的变化。结果：ＰＣＯＳ组空服血糖４．６３±０．６５ｍｍｏ１／Ｌ，ＯＧＴＴ后，有显著高血糖反应；空腹胰岛素（ＩＮＳ）与空腹β－内啡肽（β－ＥＰ）浓度及ＯＧＴＴ后ＩＮＳ净增量（平均为１８３．４４±４７．２８ｍＵ／Ｌ与β－ＥＰ净增量呈正相关（ｒ＝０．４９，Ｐ＜０．０５；ｒ＝０．３７，Ｐ＜０．０５）；ＯＧＴＴ后ＩＮＳ净增量与强啡肽（ＤｙｎＡ）净增量亦呈正相关（ｒ＝０．５８，Ｐ＜０．０１）；ＰＣＯＳ组空腹ＳＳ显著低于对照组（分别为１５６．０９±９４．０３及２１７．１４±６１．６３ｎｇ／Ｌ，Ｐ＜０．０１），但ＯＧＴＴ后两组ＳＳ浓度相似。表明：ＰＣＯＳ患者ＯＧＴＴ后糖代谢变化是一种特殊的糖耐量曲线；空腹高ＩＮＳ与ＳＳ抑制程度不足有关，而ＯＧＴＴ后高ＩＮＳ与β－ＥＰ，ＤｙｎＡ刺激程度过强有关。     

Influence of degenerative joint disease on spinal bone mineral measurements in postmenopausal women

We assessed the impact of various forms of spinal degenerative joint disease (DJD) on bone mineral density (BMD) measured by quantitative computed tomography (QCT) and dual X-ray absorptiometry (DXA) in a group of postmenopausal women. Lateral (T4-L4) and AP (L1-L4) spinal radiographs were reviewed for fracture and DJD in 209 women (mean age 62.6±6.7). The severity of DJD findings was graded as 0,1, or 2 on the lumbar films, except for vertebral osteophytes which were graded from 0 to 3. Vertebral fractures were defined semiquantitatively as approximately 20% reduction in anterior, middle, or posterior vertebral height. BMD was measured in all subjects by QCT and DXA, including posteroanterior DXA (PA-DXA), lateral DXA (L-DXA) and midlateral DXA (mL-DXA). When BMD was measured by QCT and mL-DXA in the 168 women without fractures, no significant differences were found between women with and those without DJD. However, BMD by PA-DXA was significantly higher in women with DJD changes, particularly when osteophytes were present at the vertebral bodies or facet joints. BMD by L-DXA was less affecied by DJD. For this measurement a significant increase in BMD was only noted in subjects with vertebral osteophytes. Multivariate analysis of variance (MANOVA) showed that BMD by QCT and mL-DXA was not affected by DJD. In contrast, for all women, BMD by PA-and L-DXA was affected more by DJD than by fracture status. Chi-square testing demonstrated no significant relationships between vertebral fractures and any of the DJD changes. We conclude that QCT and mL-DXA are superior to PA-DXA and L-DXA in detecting bone loss in patients with DJD. Thus, for these patients, BMD assessment by QCT or mL-DXA may be advisable.     

定量超声检测对绝经后骨质疏松症的应用价值

目的评价定量超声检测技术(QUS)对绝经后骨质疏松症的临床应用价值。方法 88例绝经后女性分别使用QUS测量左跟骨T值、双能X线吸收法(DXA)测量L1-4及髋部骨密度、T值,采用Spearman分析两种检测方法相关性。以DXA法诊断骨质疏松症(OP)为金标准,分析QUS诊断OP的ROC曲线下面积、cutoff、灵敏度、特异度、符合率、Youden指数。结果相关分析显示,QUS测量左跟骨与DXA测量L1、L2、L3、股骨颈、大转子、全髋T值相关系数分别为0.244、0.252、0.371、0.485、0.539、0.506(P0.05或P0.01);ROC曲线下面积0.669,以QUS测量T值-2.35为cutoff,QUS诊断OP的灵敏度、特异度、符合率、Youden指数分别为69.1%、65.0%、64.77%、0.341。结论 QUS与DXA检测骨密度存在相关性,可作为OP的筛查工具,但诊断效能一般,不可替代DXA检查。     

Measurement of Forearm Bone Mineral Density: Comparison of Precision of Five Different Instruments

Measurement of bone mineral density (BMD) is used for clinical estimation of fracture risk in osteoporosis. The precision of the method is important for the evaluation of true and clinical relevant changes in BMD in patients with osteoporosis. We measured BMD of the forearm in 14 young, healthy probands (10 males, 4 females), aged 24.6 ± 1.5 years with five different instruments using dual-energy X-ray absorptiometry (DXA), single-photon absorptiometry (SPA), and peripheral quantitative computed tomography (pQCT). Precision was expressed as the percentage coefficient of variation (CV%). In addition, the standardized CV% (sCV%) and the root mean square standard deviation (rmsSD%) was calculated for long-term precision. CV% ranged from 1.04 (SPA, distal BMD) to 2.75% (pQCT, trabecular BMD) for short-term precision and from 1.49 (DXA, QDR 1000, 1/3-distal BMD) to 4.33% (SPA, ultradistal) for long-term precision, respectively. The results for the rmsSD% were higher but correlated well with the CV%. A change that exceeds 2 √2 CV% has been considered as being significant. On this basis, 24.0 ± 5.1% (mean ± SEM) of the participants in our study would be expected to have a significant change in BMD without any correlation to the time-delay between the two measurements. Measurements of BMD were done at two locations with all five instruments: ultradistal and middistal BMD using DXA and SPA and total and trabecular BMD using pQCT, respectively. Coefficients of correlation for ``between-instrumental' correlation were greater than 0.5 for almost all instruments. Distal and ultradistal BMD measured by SPA and trabecular and total BMD measured by pQCT correlated better with ultradistal BMD measured by DXA. Correspondingly, ``within-instrumental' correlation was better for pQCT and SPA than for DXA. The coefficients of correlation between the different DXA methods were greater than 0.95 when corresponding locations were compared. We conclude that the clinical value of monitoring bone loss by measurement of forearm BMD is compromised by the low precision which was seen for DXA methods as well as for SPA and even pQCT in young healthy controls. Received: 26 February 1997 / Accepted: 14 November 1997     

Effect of aging on trabecular and compact bone components of proximal and ultradistal radius

Bone densitometry has become a major tool for osteoporosis risk assessment. The traditional dual-energy X-ray absorptiometry (DXA) methods are able to evaluate the bone mineral content (BMC; mg/cm) and the areal density (BMD; mg/cm²), but only quantitative computed tomography (QCT) has the potential to measure the true volumetric bone density in the sense of mass per unit volume (mg/cm³). Peripheral QCT (pQCT) measurements were carried out at the non-dominant radius using a Stratec XCT 960 (Unitrem, Roma) in 241 postmenopausal and 29 premenopausal women. The sites of evaluation were both the ultradistal and the proximal radius. The technique used has a coefficient of variation of 2% and it allows separation of the bone section into trabecular and cortical bone on the basis of density threshold. Bone mass of radius, hip and spine was also evaluated by DXA procedures. The bone density data obtained by pQCT were significantly correlated with all DXA measurements. The correlation coefficients between their respective BMD values ranged from 0.48 to 0.75, but for the BMC values of the radius the correlation coefficients ranged from 0.82 to 0.93. The BMD values measured by DXA, but not by pQCT, were positively related with patient heights. All pQCT density measurements, including those obtained at the proximal radius and containing exclusively cortical bone, where negatively related with age and years since menopause. A partial volume effect, which is increasingly relevant the thinner are the bone cortices, might explain that. However, by applying increasing density thresholds, cortical bone density seems to decrease with age as a consequence of a gradual density diminution from the inner part of the bone cortex outwards. Trabecular bone density decreases with aging, but its overall mass does not change as a consequence of an age-related enlargement of trabecular area. Thus, the proportion of trabecular bone over total bone rises, and this might be relevant for our understanding of the age-related changes in bone turnover and rate of bone loss.     

Effects of Menopause on Age-Dependent Bone Loss in the Axial and Appendicular Skeletons in Healthy Japanese Women

To determine the effects of menopause on bone loss in different parts of the skeleton, bone mineral density (BMD) values were measured longitudinally in 85 healthy women. BMD values included the lumbar spine measured by dual-energy X-ray absorptiometry (DXA) and quantitative CT (QCT) and the distal and midradius measured by DXA obtained over 5 years. BMD at the calcaneus was measured using DXA for 3 years, and the BMD values of the distal metaphyses and diaphyses of radius and tibia were measured using peripheral QCT (pQCT) for 4 years. The subjects were 19 premenopausal, 17 perimenopausal, 12 early postmenopausal and 38 late postmenopausal women with the respective average ages of 39.1 ± 7.1 (SD), 51.9 ± 2.9, 55.8 ± 1.8 and 61.9 ± 3.9 years at the start of measurement. Average years since menopause were 1.4 ± 1.8, 3.3 ± 1.3 and 12.7 ± 5.3 years, respectively. In the perimenopausal group, the annual rate of bone loss for lumbar trabecular bone measured by QCT, and for the calcaneus, and metaphyseal trabecular bone at the radius and tibia by pQCT were higher than the respective values in the premenopausal group. These values in the late postmenopausal group became significantly lower compared with those in the perimenopausal group, coming down to the level of the premenopausal group. While the annual rates of bone loss at the tibial diaphysis in the perimenopausal group were also higher than those in the premenopausal group, the values at the radial diaphysis by DXA or pQCT did not differ significantly. The reductions in the annual rates of bone loss with the passage of time after menopause were not marked in these cortical bone dominated sites. These data indicated that the annual rates of bone loss at trabecular bone dominated sites were accelerated in both axial and appendicular skeletons. Diaphyseal cortical bone, however, seemed to be less sensitive to estrogen withdrawal. Other factors, such as genetics and calcium/vitamin D metabolism, would also affect the age-dependent bone loss at the cortical bone dominated sites after menopause. Received: 30 October 1998 / Accepted: 6 April 1999     

The Range of Bone Mineral Density in Healthy Canarian Women by Dual X-ray Absorptiometry Radiography and Quantitative Computer Tomography

Bone mass measurements play a crucial role in the diagnosis of osteoporosis. According to a World Health Organization (WHO) Working Group, osteoporosis in women can be diagnosed if the value for bone mineral density (BMD) is 2.5 or more standard deviations below the mean value of a young reference population. This definition obviously requires the availability of normal data, which should ideally be obtained locally. The objective was establish normal values of BMD in the female Canarian population, by dual X-ray absorptiometry (DXA) in the lumbar spine and the proximal femur, and by quantitative computed tomography (QCT) in the lumbar spine, and to study the correlation between the results of both techniques and the changes with age. Seven hundred forty-four Healthy Canarian women, from 20-80 yr old were examined. Measurement of bone density was performed by an Hologic QDR 1000 densitometer (DXA) in the lumbar spine and proximal femur, and by a Toshiba scanner model 600 HQ in the lumbar spine. Both methods show that the peak bone mass is achieved in the fourth decade (30-39 yr). Bone density decreases thereafter with age in the lumbar spine (r = -0.3364 DXA and r = -0.6988 for QCT) and in the femoral neck (r = -0.3988). Bone density mean values obtained by DXA are very similar to those described in Spain and in other European female populations, using the same densitometer. The correlations between both techniques (DXA and QCT) were high and statistically significant (p < 0.001 in every case). Normal values in the normal Canarian women for DXA and QCT are provided. Our results are very similar to those previously described. These two techniques have a close correlation.     

A comparison of spinal quantitative computed tomography with dual energy X-ray absorptiometry in European women with vertebral and nonvertebral fractures

Quantitative computed tomography (QCT) was compared to dual X-ray absorptiometry (DXA) measured in the lumbar spine of 508 European women defined as normal without fracture (NoF), or osteoporotic (OP), with either vertebral fracture (VF), or peripheral fracture (PF). The correlations between QCT and DXA BMD measurements were significantly different in normal and in osteoporotic patients, indicating that the two exams do not measure the same bone aspects. According to ROC curves results, QCT Z-scores separate OP from NoF with better sensitivity than all other measurements. A threshold to differentiate OP from NoF was chosen at Z-score=−1 for DXA-BMD and −1.5 for QCT-BMD. VF patients showed a highly significant decrease in BMD by DXA or QCT. PF patients revealed measurements lower than those of normal subjects but greater than those of VF, calling into question the idea of a diffuse osteoporosis causing nonvertebral fractures that is measurable by spinal DXA or QCT. DXA is weakly dependent upon age, and T-score or Z-score are equivalent for evaluating osteoporosis. QCT depends greatly upon age, and Z-score appears to be more efficient.     

Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial.

Glucocorticoid-induced osteoporosis is the most common secondary cause of osteoporosis. In this 24-month study, we report changes in bone turnover and bone mass after 12 months of daily injections of human parathyroid hormone 1-34 [hPTH(1-34)] and 12 months off treatment in postmenopausal women (mean age, 63 years) with osteoporosis treated with glucocorticoid and hormone replacement therapy. Response to the treatment was assessed with bone mineral density (BMD) measurements of the lumbar spine by quantitative computed tomography (QCT); BMD measurements of the lumbar spine, hip, and forearm by dual-energy X-ray absorptiometry (DXA); and biochemical markers of bone turnover. The mean (+/-SEM) change in BMD of the lumbar spine by QCT and DXA in the PTH group at 24 months was 45.9+/-6.4% and 12.6+/-2.2% (p < 0.001). The change in total hip and femoral neck BMD was not significant at 12 months but increased to 4.7+/-0.9% (p < 0.01) and 5.2+/-1.3% at 24 months, respectively, as compared with a relatively small change of 1.3+/-0.9% and 2.6+/-1.7% in the estrogen-only group. The mean percent differences in BMD of the lumbar spine by QCT and DXA between the groups at 24 months were 43.1% and 11.9%, respectively (p < 0.001). The mean percent differences over the estrogen-only group in hip BMD were 3.4% for total hip (p < 0.01) and 2.6% for femoral neck at 24 months. Biochemical markers of bone turnover increased to more than 150% during the first 6 months of therapy, remained elevated throughout the 12-month treatment period, and returned to baseline values within 6 months of discontinuing the PTH treatment. These results suggest that PTH dramatically increases bone mass in the lumbar spine and hip in postmenopausal women with glucocorticoid-induced osteoporosis who are taking hormone replacement therapy. However, the maximum effect of this anabolic agent on bone mass at the hip after 12 months of treatment requires at least 6-12 months after the PTH treatment is discontinued.     

Assessment of bone density using the 1.5 T or 3.0 T MRI-based vertebral bone quality score in older patients undergoing spine surgery: does field strength matter?

BACKGROUND CONTEXTRecently published studies have revealed a correlation between MRI-based vertebral bone quality (VBQ) score and bone mineral density (BMD) measured using dual X-ray absorptiometry (DXA) or quantitative computed tomography (QCT). However, no studies have determined if differences in field strength (1.5 vs 3.0 T) could affect the comparability of the VBQ score among different individuals.PURPOSETo compare the VBQ score obtained from 1.5 T and 3.0 T MRI (VBQ_1.5T vs VBQ_3.0T) in patients undergoing spine surgery and assess the predictive performance of VBQ for osteoporosis and osteoporotic vertebral fracture (VCF).DESIGNA nested case‒control study based on an ongoing prospective cohort study of patients undergoing spine surgery.PATIENT SAMPLEAll older patients (men aged >60 years and postmenopausal women) with available DXA, QCT and MR images within 1 month were included.OUTCOME MEASURESVBQ score, DXA T-score, and QCT derived vBMD.METHODSThe osteoporotic classifications recommended by the World Health Organization and American College of Radiology were used to categorize the DXA T-score and QCT-derived BMD, respectively. For each patient, the VBQ score was calculated using T1-weighted MR images. Correlation analysis between VBQ and DXA/QCT was performed. Receiver operating characteristic (ROC) curve analysis, including determination of the area under the curve (AUC), was performed to assess the predictive performance of VBQ for osteoporosis.ResultsA total of 452 patients (98 men aged >60 years and 354 postmenopausal women) were included in the analysis. Across different BMD categories, the correlation coefficients between the VBQ score and BMD ranged from -0.211 to -0.511, and the VBQ_1.5T score and QCT BMD demonstrated the strongest correlation. The VBQ score was a significant classifier of osteoporosis detected by either DXA or QCT, with VBQ_1.5T showing the highest discriminative power for QCT-osteoporosis (AUC=0.744, 95% CI=0.685–0.803). In ROC analysis, the VBQ_1.5T threshold values ranged from 3.705 to 3.835 with a sensitivity between 48% and 55.6% and a specificity between 70.8% and 74.8%, while the VBQ_3.0T threshold values ranged from 2.59 to 2.605 with a sensitivity between 57.6% and 67.1% and a specificity between 67.8% and 69.7%.CONCLUSIONSVBQ_1.5T exhibited better discriminability between patients with and without osteoporosis than VBQ_3.0T. Considering the non-negligible difference in osteoporosis diagnosis threshold values between the VBQ_1.5T and VBQ_3.0T scores, it is essential to clearly distinguish the magnetic field strength when assessing the VBQ score.     

mDIXON-Quant技术评估中老年女性骨质量的临床研究

目的 探讨中老年女性腰椎骨髓脂肪分数(fat fraction,FF)和T2?值与骨密度(bone mineral density,BMD)的关联性及mDIXON-Quant技术对骨量下降的诊断效能.方法 招募中老年女性健康志愿者共126名,采用双能X线吸收测量仪(dual-energy X-ray absorptio...